KYBELLA® (deoxycholic acid) is the first and only FDA-approved injectable treatment to
improve the appearance of moderate to severe fat beneath the chin by physically
destroying fat cells.
Once destroyed, those cells can no longer store or accumulate fat. In the pivotal clinical studies, based on composite clinician and patient ratings scales, 68.2% and 16% of KYBELLA-treated subjects had 1-grade and 2-grade improvement after final treatment, versus 20.5% and 1.5% of those treated with placebo, respectively.
79% of people treated with KYBELLA® had improved satisfaction with the appearance of the area beneath their chin (compared with 34% of people treated with placebo) 12 weeks
after their last treatment.
KYBELLA® patients reported improvement in the visual and emotional impact of submental fat when asked how happy, bothered, self-conscious, embarrassed, old, and overweight they felt with respect to the amount of their submental fat after they received treatment.
improve the appearance of moderate to severe fat beneath the chin by physically
destroying fat cells.
Once destroyed, those cells can no longer store or accumulate fat. In the pivotal clinical studies, based on composite clinician and patient ratings scales, 68.2% and 16% of KYBELLA-treated subjects had 1-grade and 2-grade improvement after final treatment, versus 20.5% and 1.5% of those treated with placebo, respectively.
79% of people treated with KYBELLA® had improved satisfaction with the appearance of the area beneath their chin (compared with 34% of people treated with placebo) 12 weeks
after their last treatment.
KYBELLA® patients reported improvement in the visual and emotional impact of submental fat when asked how happy, bothered, self-conscious, embarrassed, old, and overweight they felt with respect to the amount of their submental fat after they received treatment.
